Patent · US Active

Compounds and methods for modulating Interleukin-2-inducible T-cell kinase

US11897874B2 · kind B2 · utility

0Cited by
3References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 7, 2021
Grant dateFeb 13, 2024
Priority date—
Expiry dateDec 18, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D495/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided herein, inter alia, are methods and compounds for modulating Interleukin-2-inducible T-cell kinase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.